aluates Reports

$ 0.0

Automative

Global Substance Abuse Therapeutics Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-29I18494

Global Substance Abuse Therapeutics Market Insights Forecast to 2030

BUY CHAPTERS

Global Substance Abuse Therapeutics Market Research Report 2025

Code: QYRE-Auto-29I18494

Report

July 2025

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Alkermes plc

Novartis

Mylan NV

Cipla Ltd

Glenmark

Dr. Reddy’s Laboratories

Teva Pharmaceutical

Substance Abuse Therapeutics Market Size

The global market for Substance Abuse Therapeutics was valued at US$ 20230 million in the year 2024 and is projected to reach a revised size of US$ 31020 million by 2031, growing at a CAGR of 6.4% during the forecast period.

Substance Abuse Therapeutics Market

Substance Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of substance abuse. Some commonly used drug for treatment of substance abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Substance Abuse Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Substance Abuse Therapeutics.

The Substance Abuse Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Substance Abuse Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Substance Abuse Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Substance Abuse Therapeutics Market Report

Report Metric	Details
Report Name	Substance Abuse Therapeutics Market
Accounted market size in year	US$ 20230 million
Forecasted market size in 2031	US$ 31020 million
CAGR	6.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Opioid Addiction Tobacco/Nicotine Addiction Alcohol Dependence
Segment by Application	Hospital & Clinics Residential (non-hospital)
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy's Laboratories, Teva Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Substance Abuse Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Substance Abuse Therapeutics Market growing?

Ans: The Substance Abuse Therapeutics Market witnessing a CAGR of 6.4% during the forecast period 2025-2031.

What is the Substance Abuse Therapeutics Market size in 2031?

Ans: The Substance Abuse Therapeutics Market size in 2031 will be US$ 31020 million.

Who are the main players in the Substance Abuse Therapeutics Market report?

Ans: The main players in the Substance Abuse Therapeutics Market are Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy's Laboratories, Teva Pharmaceutical

What are the Application segmentation covered in the Substance Abuse Therapeutics Market report?

Ans: The Applications covered in the Substance Abuse Therapeutics Market report are Hospital & Clinics, Residential (non-hospital)

What are the Type segmentation covered in the Substance Abuse Therapeutics Market report?

Ans: The Types covered in the Substance Abuse Therapeutics Market report are Opioid Addiction, Tobacco/Nicotine Addiction, Alcohol Dependence

Recommended Reports

Substance Abuse Treatments

Neurological & Mental Health

Liver & Critical Care

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Substance Abuse Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Opioid Addiction

1.2.3 Tobacco/Nicotine Addiction

1.2.4 Alcohol Dependence

1.3 Market by Application

1.3.1 Global Substance Abuse Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital & Clinics

1.3.3 Residential (non-hospital)

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Substance Abuse Therapeutics Market Perspective (2020-2031)

2.2 Global Substance Abuse Therapeutics Growth Trends by Region

2.2.1 Global Substance Abuse Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Substance Abuse Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Substance Abuse Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Substance Abuse Therapeutics Market Dynamics

2.3.1 Substance Abuse Therapeutics Industry Trends

2.3.2 Substance Abuse Therapeutics Market Drivers

2.3.3 Substance Abuse Therapeutics Market Challenges

2.3.4 Substance Abuse Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Substance Abuse Therapeutics Players by Revenue

3.1.1 Global Top Substance Abuse Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Substance Abuse Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Substance Abuse Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Substance Abuse Therapeutics Revenue

3.4 Global Substance Abuse Therapeutics Market Concentration Ratio

3.4.1 Global Substance Abuse Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Substance Abuse Therapeutics Revenue in 2024

3.5 Global Key Players of Substance Abuse Therapeutics Head office and Area Served

3.6 Global Key Players of Substance Abuse Therapeutics, Product and Application

3.7 Global Key Players of Substance Abuse Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Substance Abuse Therapeutics Breakdown Data by Type

4.1 Global Substance Abuse Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Substance Abuse Therapeutics Forecasted Market Size by Type (2026-2031)

5 Substance Abuse Therapeutics Breakdown Data by Application

5.1 Global Substance Abuse Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Substance Abuse Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Substance Abuse Therapeutics Market Size (2020-2031)

6.2 North America Substance Abuse Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Substance Abuse Therapeutics Market Size by Country (2020-2025)

6.4 North America Substance Abuse Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Substance Abuse Therapeutics Market Size (2020-2031)

7.2 Europe Substance Abuse Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Substance Abuse Therapeutics Market Size by Country (2020-2025)

7.4 Europe Substance Abuse Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Substance Abuse Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Substance Abuse Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Substance Abuse Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Substance Abuse Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Substance Abuse Therapeutics Market Size (2020-2031)

9.2 Latin America Substance Abuse Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Substance Abuse Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Substance Abuse Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Substance Abuse Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Substance Abuse Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Substance Abuse Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Substance Abuse Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Indivior

11.1.1 Indivior Company Details

11.1.2 Indivior Business Overview

11.1.3 Indivior Substance Abuse Therapeutics Introduction

11.1.4 Indivior Revenue in Substance Abuse Therapeutics Business (2020-2025)

11.1.5 Indivior Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Substance Abuse Therapeutics Introduction

11.2.4 Pfizer Revenue in Substance Abuse Therapeutics Business (2020-2025)

11.2.5 Pfizer Recent Development

11.3 Alkermes

11.3.1 Alkermes Company Details

11.3.2 Alkermes Business Overview

11.3.3 Alkermes Substance Abuse Therapeutics Introduction

11.3.4 Alkermes Revenue in Substance Abuse Therapeutics Business (2020-2025)

11.3.5 Alkermes Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Substance Abuse Therapeutics Introduction

11.4.4 Novartis Revenue in Substance Abuse Therapeutics Business (2020-2025)

11.4.5 Novartis Recent Development

11.5 Mylan

11.5.1 Mylan Company Details

11.5.2 Mylan Business Overview

11.5.3 Mylan Substance Abuse Therapeutics Introduction

11.5.4 Mylan Revenue in Substance Abuse Therapeutics Business (2020-2025)

11.5.5 Mylan Recent Development

11.6 Cipla

11.6.1 Cipla Company Details

11.6.2 Cipla Business Overview

11.6.3 Cipla Substance Abuse Therapeutics Introduction

11.6.4 Cipla Revenue in Substance Abuse Therapeutics Business (2020-2025)

11.6.5 Cipla Recent Development

11.7 Glenmark

11.7.1 Glenmark Company Details

11.7.2 Glenmark Business Overview

11.7.3 Glenmark Substance Abuse Therapeutics Introduction

11.7.4 Glenmark Revenue in Substance Abuse Therapeutics Business (2020-2025)

11.7.5 Glenmark Recent Development

11.8 Dr. Reddy's Laboratories

11.8.1 Dr. Reddy's Laboratories Company Details

11.8.2 Dr. Reddy's Laboratories Business Overview

11.8.3 Dr. Reddy's Laboratories Substance Abuse Therapeutics Introduction

11.8.4 Dr. Reddy's Laboratories Revenue in Substance Abuse Therapeutics Business (2020-2025)

11.8.5 Dr. Reddy's Laboratories Recent Development

11.9 Teva Pharmaceutical

11.9.1 Teva Pharmaceutical Company Details

11.9.2 Teva Pharmaceutical Business Overview

11.9.3 Teva Pharmaceutical Substance Abuse Therapeutics Introduction

11.9.4 Teva Pharmaceutical Revenue in Substance Abuse Therapeutics Business (2020-2025)

11.9.5 Teva Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Alkermes plc

Novartis

Mylan NV

Cipla Ltd

Glenmark

Dr. Reddy’s Laboratories

Teva Pharmaceutical

List of Tables

Table 1. Global Substance Abuse Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Opioid Addiction

Table 3. Key Players of Tobacco/Nicotine Addiction

Table 4. Key Players of Alcohol Dependence

Table 5. Global Substance Abuse Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Substance Abuse Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Substance Abuse Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Substance Abuse Therapeutics Market Share by Region (2020-2025)

Table 9. Global Substance Abuse Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Substance Abuse Therapeutics Market Share by Region (2026-2031)

Table 11. Substance Abuse Therapeutics Market Trends

Table 12. Substance Abuse Therapeutics Market Drivers

Table 13. Substance Abuse Therapeutics Market Challenges

Table 14. Substance Abuse Therapeutics Market Restraints

Table 15. Global Substance Abuse Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Substance Abuse Therapeutics Market Share by Players (2020-2025)

Table 17. Global Top Substance Abuse Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Substance Abuse Therapeutics as of 2024)

Table 18. Ranking of Global Top Substance Abuse Therapeutics Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Substance Abuse Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Substance Abuse Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of Substance Abuse Therapeutics, Product and Application

Table 22. Global Key Players of Substance Abuse Therapeutics, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Substance Abuse Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Substance Abuse Therapeutics Revenue Market Share by Type (2020-2025)

Table 26. Global Substance Abuse Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Substance Abuse Therapeutics Revenue Market Share by Type (2026-2031)

Table 28. Global Substance Abuse Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Substance Abuse Therapeutics Revenue Market Share by Application (2020-2025)

Table 30. Global Substance Abuse Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Substance Abuse Therapeutics Revenue Market Share by Application (2026-2031)

Table 32. North America Substance Abuse Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Substance Abuse Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Substance Abuse Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Substance Abuse Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Substance Abuse Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Substance Abuse Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Substance Abuse Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Substance Abuse Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Substance Abuse Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Substance Abuse Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Substance Abuse Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Substance Abuse Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Substance Abuse Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Substance Abuse Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Substance Abuse Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 47. Indivior Company Details

Table 48. Indivior Business Overview

Table 49. Indivior Substance Abuse Therapeutics Product

Table 50. Indivior Revenue in Substance Abuse Therapeutics Business (2020-2025) & (US$ Million)

Table 51. Indivior Recent Development

Table 52. Pfizer Company Details

Table 53. Pfizer Business Overview

Table 54. Pfizer Substance Abuse Therapeutics Product

Table 55. Pfizer Revenue in Substance Abuse Therapeutics Business (2020-2025) & (US$ Million)

Table 56. Pfizer Recent Development

Table 57. Alkermes Company Details

Table 58. Alkermes Business Overview

Table 59. Alkermes Substance Abuse Therapeutics Product

Table 60. Alkermes Revenue in Substance Abuse Therapeutics Business (2020-2025) & (US$ Million)

Table 61. Alkermes Recent Development

Table 62. Novartis Company Details

Table 63. Novartis Business Overview

Table 64. Novartis Substance Abuse Therapeutics Product

Table 65. Novartis Revenue in Substance Abuse Therapeutics Business (2020-2025) & (US$ Million)

Table 66. Novartis Recent Development

Table 67. Mylan Company Details

Table 68. Mylan Business Overview

Table 69. Mylan Substance Abuse Therapeutics Product

Table 70. Mylan Revenue in Substance Abuse Therapeutics Business (2020-2025) & (US$ Million)

Table 71. Mylan Recent Development

Table 72. Cipla Company Details

Table 73. Cipla Business Overview

Table 74. Cipla Substance Abuse Therapeutics Product

Table 75. Cipla Revenue in Substance Abuse Therapeutics Business (2020-2025) & (US$ Million)

Table 76. Cipla Recent Development

Table 77. Glenmark Company Details

Table 78. Glenmark Business Overview

Table 79. Glenmark Substance Abuse Therapeutics Product

Table 80. Glenmark Revenue in Substance Abuse Therapeutics Business (2020-2025) & (US$ Million)

Table 81. Glenmark Recent Development

Table 82. Dr. Reddy's Laboratories Company Details

Table 83. Dr. Reddy's Laboratories Business Overview

Table 84. Dr. Reddy's Laboratories Substance Abuse Therapeutics Product

Table 85. Dr. Reddy's Laboratories Revenue in Substance Abuse Therapeutics Business (2020-2025) & (US$ Million)

Table 86. Dr. Reddy's Laboratories Recent Development

Table 87. Teva Pharmaceutical Company Details

Table 88. Teva Pharmaceutical Business Overview

Table 89. Teva Pharmaceutical Substance Abuse Therapeutics Product

Table 90. Teva Pharmaceutical Revenue in Substance Abuse Therapeutics Business (2020-2025) & (US$ Million)

Table 91. Teva Pharmaceutical Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

Table 95. Authors List of This Report

List of Figures

Figure 1. Substance Abuse Therapeutics Picture

Figure 2. Global Substance Abuse Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Substance Abuse Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Opioid Addiction Features

Figure 5. Tobacco/Nicotine Addiction Features

Figure 6. Alcohol Dependence Features

Figure 7. Global Substance Abuse Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Substance Abuse Therapeutics Market Share by Application: 2024 VS 2031

Figure 9. Hospital & Clinics Case Studies

Figure 10. Residential (non-hospital) Case Studies

Figure 11. Substance Abuse Therapeutics Report Years Considered

Figure 12. Global Substance Abuse Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Substance Abuse Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Substance Abuse Therapeutics Market Share by Region: 2024 VS 2031

Figure 15. Global Substance Abuse Therapeutics Market Share by Players in 2024

Figure 16. Global Top Substance Abuse Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Substance Abuse Therapeutics as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Substance Abuse Therapeutics Revenue in 2024

Figure 18. North America Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Substance Abuse Therapeutics Market Share by Country (2020-2031)

Figure 20. United States Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Substance Abuse Therapeutics Market Share by Country (2020-2031)

Figure 24. Germany Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Substance Abuse Therapeutics Market Share by Region (2020-2031)

Figure 32. China Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Substance Abuse Therapeutics Market Share by Country (2020-2031)

Figure 40. Mexico Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Substance Abuse Therapeutics Market Share by Country (2020-2031)

Figure 44. Turkey Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Substance Abuse Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Indivior Revenue Growth Rate in Substance Abuse Therapeutics Business (2020-2025)

Figure 48. Pfizer Revenue Growth Rate in Substance Abuse Therapeutics Business (2020-2025)

Figure 49. Alkermes Revenue Growth Rate in Substance Abuse Therapeutics Business (2020-2025)

Figure 50. Novartis Revenue Growth Rate in Substance Abuse Therapeutics Business (2020-2025)

Figure 51. Mylan Revenue Growth Rate in Substance Abuse Therapeutics Business (2020-2025)

Figure 52. Cipla Revenue Growth Rate in Substance Abuse Therapeutics Business (2020-2025)

Figure 53. Glenmark Revenue Growth Rate in Substance Abuse Therapeutics Business (2020-2025)

Figure 54. Dr. Reddy's Laboratories Revenue Growth Rate in Substance Abuse Therapeutics Business (2020-2025)

Figure 55. Teva Pharmaceutical Revenue Growth Rate in Substance Abuse Therapeutics Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Addictions Therapeutics Market Insights Forecast to 2030

Substance Use Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Addiction Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Addiction Treatment Market Research Report 2024

Global Opioid Withdrawal Treatment Market Insights Forecast to 2030

Global Alcohol Addiction Therapeutics Market Research Report 2024

Global Substance Abuse EMR Software Market Insights Forecast to 2030

Opioid Dependence Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nicotine Addiction Treatment Market Research Report 2025

Global Smoking Cessation and Addiction Treatments Market Research Report 2024

Nicotine Addiction Treatment Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Abuse Screening Market Research Report 2025

Addiction Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Substance Abuse Testing Services Market Research Report 2025

Global Opioid Use Disorder Market Insights Forecast to 2030

Global Drugs of Abuse Analysis Controls Market Research Report 2024

Global Alcoholic Hepatitis Treatment Market Insights Forecast to 2030

Global Drug of Abuse Screening Market Research Report 2025

Alcohol and Drug Abuse Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions